RC Schuit
RC Schuit
VU medical center
Verifierad e-postadress på vumc.nl
Citeras av
Citeras av
Δ9-tetrahydrocannabinol induces dopamine release in the human striatum
MG Bossong, BN Van Berckel, R Boellaard, L Zuurman, RC Schuit, ...
Neuropsychopharmacology 34 (3), 759-766, 2009
Blood–brain barrier P-glycoprotein function in Alzheimer's disease
DME van Assema, M Lubberink, M Bauer, WM van der Flier, RC Schuit, ...
Brain 135 (1), 181-189, 2012
PET imaging of α v β 3 integrin expression in tumours with 68 Ga-labelled mono-, di-and tetrameric RGD peptides
I Dijkgraaf, CB Yim, GM Franssen, RC Schuit, G Luurtsema, S Liu, ...
European journal of nuclear medicine and molecular imaging 38 (1), 128-137, 2011
Evaluation of (R)-[11C] verapamil as PET tracer of P-glycoprotein function in the blood–brain barrier: kinetics and metabolism in the rat
G Luurtsema, CFM Molthoff, RC Schuit, AD Windhorst, AA Lammertsma, ...
Nuclear medicine and biology 32 (1), 87-93, 2005
Myoclonus‐dystonia: significance of large SGCE deletions
A Grünewald, A Djarmati, K Lohmann‐Hedrich, K Farrell, JA Zeller, ...
Human mutation 29 (2), 331-332, 2008
Development of [11C] erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status
I Bahce, EF Smit, M Lubberink, AAM van der Veldt, M Yaqub, ...
Clinical Cancer Research 19 (1), 183-193, 2013
P-glycoprotein function at the blood–brain barrier: effects of age and gender
DME van Assema, M Lubberink, R Boellaard, RC Schuit, AD Windhorst, ...
Molecular imaging and biology 14 (6), 771-776, 2012
Quantification of [18F]DPA-714 Binding in the Human Brain: Initial Studies in Healthy Controls and Alzheimer'S Disease Patients
SSV Golla, R Boellaard, V Oikonen, A Hoffmann, BNM Van Berckel, ...
Journal of Cerebral Blood Flow & Metabolism 35 (5), 766-772, 2015
Evaluation of [11C] laniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in rats
G Luurtsema, RC Schuit, RP Klok, J Verbeek, JE Leysen, ...
Nuclear medicine and biology 36 (6), 643-649, 2009
Right ventricular failure in idiopathic pulmonary arterial hypertension is associated with inefficient myocardial oxygen utilization
YY Wong, G Ruiter, M Lubberink, PG Raijmakers, P Knaapen, JT Marcus, ...
Circulation: Heart Failure 4 (6), 700-706, 2011
89Zr-cetuximab PET imaging in patients with advanced colorectal cancer
CW Menke-van der Houven, ECG van Oordt, MC Huisman, DJ Vugts, ...
Oncotarget 6 (30), 30384, 2015
Synthesis and initial preclinical evaluation of the P2X7 receptor antagonist [11C] A‐740003 as a novel tracer of neuroinflammation
B Janssen, DJ Vugts, U Funke, A Spaans, RC Schuit, E Kooijman, ...
Journal of Labelled Compounds and Radiopharmaceuticals 57 (8), 509-516, 2014
Blood–brain barrier P-glycoprotein function in healthy subjects and Alzheimer's disease patients: effect of polymorphisms in the ABCB1 gene
DME van Assema, M Lubberink, P Rizzu, JC van Swieten, RC Schuit, ...
EJNMMI research 2 (1), 1-6, 2012
Rapid and quantitative analysis of unconjugated C27 bile acids in plasma and blood samples by tandem mass spectrometry
DW Johnson, HJ Ten Brink, RC Schuit, C Jakobs
Journal of lipid research 42 (1), 9-16, 2001
Array CGH in molecular diagnosis of mental retardation—a study of 150 finnish patients
L Siggberg, S Ala‐Mello, E Jaakkola, E Kuusinen, R Schuit, J Kohlhase, ...
American Journal of Medical Genetics Part A 152 (6), 1398-1410, 2010
Development of [18F] afatinib as new TKI-PET tracer for EGFR positive tumors
P Slobbe, AD Windhorst, M Stigter-van Walsum, RC Schuit, EF Smit, ...
Nuclear medicine and biology 41 (9), 749-757, 2014
Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C] benzyl]-morpholine: evaluation of a potential PET ligand
AJ Airaksinen, JA Jablonowski, M van der Mey, AJ Barbier, RP Klok, ...
Nuclear medicine and biology 33 (6), 801-810, 2006
Quantification of 18F-fluorocholine kinetics in patients with prostate cancer
EE Verwer, DE Oprea-Lager, AJM van den Eertwegh, ...
Journal of Nuclear Medicine 56 (3), 365-371, 2015
Peripheral metabolism of [18F] FDDNP and cerebral uptake of its labelled metabolites
G Luurtsema, RC Schuit, K Takkenkamp, M Lubberink, NH Hendrikse, ...
Nuclear medicine and biology 35 (8), 869-874, 2008
Identification of the allosteric P2X 7 receptor antagonist [11 C] SMW139 as a PET tracer of microglial activation
B Janssen, DJ Vugts, SM Wilkinson, D Ory, S Chalon, JJM Hoozemans, ...
Scientific reports 8 (1), 1-10, 2018
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20